Trump's doctor admits he withheld details of treatment to 'reflect upbeat attitude'
The doctor also admitted his statements ‘came off like we’re trying to hide something.’
Donald Trump’s physician says he was trying to “reflect the upbeat attitude” of the president and his medical team when he declined to share Saturday that Trump was placed on oxygen the day before.
Navy Cmdr. Dr. Sean Conley was pressed Sunday on why his rosy picture of Trump’s health was contradicted moments later by White House chief of staff Mark Meadows, who expressed that the medical team was very concerned with the president’s health Friday morning when he experienced a drop in his blood oxygen levels and had a high fever.
Said Conley: “I was trying to reflect the upbeat attitude of the team, that the president, that his course of illness has had.”
He added that he “didn’t want to give any information that might steer the course of illness in another direction. And in doing so, came off like we’re trying to hide something, which wasn’t necessarily true.”
Trump’s team of doctors says he is doing well after his COVID-19 diagnosis and could be discharged as early as Monday to continue his treatment.
Dr. Brian Garibaldi, a specialist in pulmonary critical care, said Trump received a second dose of the experimental drug remdesivir along with a first dose of dexamethasone Saturday and isn’t showing any side effects “that we can tell.”
He said Sunday that Trump is “up and well” and the plan was to have him “out of bed” Sunday as much as possible.
Garibaldi and Conley said if things continue to go well, Trump will be able to return to the White House on Monday to continue his five-day course of remdesivir treatment and other appropriate therapy.
Conley also said Trump was treated with a steroid after a drop in oxygen levels on Saturday. He said Trump’s oxygen level had dropped down to 93% on Saturday. He says the Trump did not feel short of breath.
Recommended
Cost, access still barriers to medical care for Black Ohio women
A recent study recommended increases in Medicaid eligibility and other legislative measures to help improve health care outcomes and access for Black women in Ohio, while still spotlighting fears of discrimination among women seeking care.
By Susan Tebben, Ohio Capital Journal - October 15, 2024
Texas’ abortion laws are straining the OB/GYN workforce, new study shows
More doctors are considering leaving or retiring early, while fewer medical students are applying to obstetrics and gynecology residencies in Texas.
By Eleanor Klibanoff, Texas Tribune - October 08, 2024
Rogers says Medicare negotiating drug price reductions is ‘sugar high politics’
Former U.S. Rep. Mike Rogers (R-White Lake)said he was “passionately against” allowing Medicare to negotiate drug prices, which he referred to as “sugar high politics.”
By Jon King, Michigan Advance - October 02, 2024
